DK1140942T3 - Prenyltransferaseinhibitorer - Google Patents

Prenyltransferaseinhibitorer

Info

Publication number
DK1140942T3
DK1140942T3 DK99968984T DK99968984T DK1140942T3 DK 1140942 T3 DK1140942 T3 DK 1140942T3 DK 99968984 T DK99968984 T DK 99968984T DK 99968984 T DK99968984 T DK 99968984T DK 1140942 T3 DK1140942 T3 DK 1140942T3
Authority
DK
Denmark
Prior art keywords
transferase inhibitors
prenyl transferase
chem
bond
prenyl
Prior art date
Application number
DK99968984T
Other languages
English (en)
Inventor
Barry A Morgan
Thomas D Gordon
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK1140942T3 publication Critical patent/DK1140942T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99968984T 1998-12-31 1999-12-30 Prenyltransferaseinhibitorer DK1140942T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11430198P 1998-12-31 1998-12-31
US22442898A 1998-12-31 1998-12-31

Publications (1)

Publication Number Publication Date
DK1140942T3 true DK1140942T3 (da) 2004-05-24

Family

ID=26812031

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99968984T DK1140942T3 (da) 1998-12-31 1999-12-30 Prenyltransferaseinhibitorer

Country Status (14)

Country Link
US (2) US7361656B2 (da)
EP (2) EP1382607B1 (da)
AT (2) ATE261447T1 (da)
AU (1) AU2717100A (da)
CA (1) CA2356756A1 (da)
CZ (1) CZ20012358A3 (da)
DE (2) DE69941307D1 (da)
DK (1) DK1140942T3 (da)
ES (2) ES2215420T3 (da)
HU (1) HUP0104708A3 (da)
NO (1) NO321057B1 (da)
PT (1) PT1140942E (da)
RU (1) RU2241712C9 (da)
WO (1) WO2000039130A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812546B1 (fr) * 2000-08-01 2008-11-21 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
US20060166907A1 (en) * 2002-09-27 2006-07-27 Gregoire Prevost Composition for the treatment of nasopharyngeal carcinoma and method of use thereof
EP2102189B1 (en) * 2006-12-15 2015-07-29 Bristol-Myers Squibb Company Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
JO3156B1 (ar) * 2009-07-09 2017-09-20 Novartis Ag ايميدازولات مدمجة والتركيبات التي تشملها لعلاج الأمراض الطفيلية على مثال الملاريا
EP2508511A1 (en) 2011-04-07 2012-10-10 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses
ES2681593T3 (es) * 2012-11-29 2018-09-14 Chemocentryx, Inc. Antagonistas de CXCR7
CN106317057B (zh) * 2015-07-02 2019-02-01 北京桦冠医药科技有限公司 具有咪唑并吡嗪类衍生物，其制备及其在医药上的应用
AU2018260414A1 (en) 2017-04-24 2019-10-17 Novartis Ag Therapeutic regimen of 2-amino-l-(2-(4-fluorophenyl)-3-(4-fluorophenylamino)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)ethanone and combinations thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0460116T3 (da) * 1989-02-27 1998-03-30 Biocryst Pharm Inc 9-substitueret-8-usubstitueret-9-deazaguaniner
RU2092487C1 (ru) * 1992-04-24 1997-10-10 Ньюроджен Корпорейшн Имидазохиноксалины
WO1994026723A2 (en) * 1993-05-14 1994-11-24 Genentech, Inc. ras FARNESYL TRANSFERASE INHIBITORS
US5488109A (en) 1993-11-05 1996-01-30 Dowelanco 5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine-2(3H)--thione compounds and their use in the preparation of and 2-chlorosulfonyl-5-alkoxy[1,2,4]triazolo[1,5-c]-pyrimidine compounds
US5488189A (en) * 1993-12-14 1996-01-30 E. I. Du Pont De Nemours And Company Process for fluorinated propanes and pentanes
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors
FR2780974B1 (fr) * 1998-07-08 2001-09-28 Sod Conseils Rech Applic Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
UA74912C2 (en) * 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes

Also Published As

Publication number Publication date
EP1140942B1 (en) 2004-03-10
ES2328564T3 (es) 2009-11-16
HUP0104708A3 (en) 2004-05-28
ATE261447T1 (de) 2004-03-15
NO321057B1 (no) 2006-03-06
NO20013281L (no) 2001-08-29
WO2000039130A3 (en) 2000-11-02
DE69941307D1 (de) 2009-10-01
EP1382607A2 (en) 2004-01-21
RU2241712C9 (ru) 2006-04-20
EP1140942A2 (en) 2001-10-10
AU2717100A (en) 2000-07-31
DE69915514T2 (de) 2005-01-05
ATE440100T1 (de) 2009-09-15
WO2000039130A2 (en) 2000-07-06
NO20013281D0 (no) 2001-06-29
ES2215420T3 (es) 2004-10-01
PT1140942E (pt) 2004-05-31
RU2241712C2 (ru) 2004-12-10
CA2356756A1 (en) 2000-07-06
US7691859B2 (en) 2010-04-06
HUP0104708A2 (hu) 2002-04-29
US20080176835A1 (en) 2008-07-24
US20060142275A1 (en) 2006-06-29
CZ20012358A3 (cs) 2002-01-16
DE69915514D1 (de) 2004-04-15
US7361656B2 (en) 2008-04-22
EP1382607A3 (en) 2004-06-30
EP1382607B1 (en) 2009-08-19

Similar Documents

Publication Publication Date Title
EP0976748A4 (en) PYRROLIDIN DERIVATIVES HAVING A PHOSPHOLIPASE A2 INHIBITING EFFECT
DK0931788T3 (da) Metalloproteasehæmmere
MY136141A (en) Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors
DK1022272T3 (da) Substituerede, fusionerede, heterocykliske forbindelser
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DK1265606T3 (da) Celleadhæsionsinhibitorer
GB9625045D0 (en) Parasiticidal compounds
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
PT918776E (pt) Sintese total de acilfulvenos antitumorais
DE69426602D1 (de) 2,3-diaminopropionsäurederivate
DE69941307D1 (de) Prenyl transferasinhibitoren
DK0784055T3 (da) Pyrimidinylpyrazolderivater
BRPI0411664A (pt) composição oral antiplaca aquosa estável
DE69813554D1 (de) Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer
ATE356112T1 (de) Thio-derivate als würzende bestandteile
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
BR0101556A (pt) Composto heterocìclico